Screener
Aurinia Pharmaceuticals AUPH Net Income
Net Income at other companies
Other financials
Where this comes from
Reported directly by Aurinia Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:NetIncomeLoss.
The source filing: Aurinia Pharmaceuticals’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 8:16 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001600620-26-000062
FAQ
- What is Aurinia Pharmaceuticals's net income?
- Aurinia Pharmaceuticals (AUPH) reported net income of $37.41M in Q2 2026.
- How has Aurinia Pharmaceuticals's net income changed year-over-year?
- Aurinia Pharmaceuticals's net income increased by 73.9% year-over-year, from $21.51M to $37.41M.
- What is the long-term trend for Aurinia Pharmaceuticals's net income?
- Over 4 years (2021 to 2025), Aurinia Pharmaceuticals's net income has grown at a 12.2% compound annual growth rate (CAGR), from -$180.97M to $287.2M.
- What does net income mean?
- Net income as the starting point for the indirect method operating cash flow reconciliation.
Ask your AI about Aurinia Pharmaceuticals's net income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude